TrialThe oncologist2025
Efficacy and safety of anamorelin in patients with metastatic urothelial carcinoma receiving systemic chemotherapy: a randomized controlled study.
Kunihiro Odagiri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.